14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Gain-of-function mutations in the chloride channel ClC-2 were recently described as a cause of familial hyperaldosteronism type II (FH-II). Here, we report the generation of a mouse model carrying a missense mutation homologous to the most common FH-II-associated CLCN2 mutation. In these Clcn2 R180Q/+ mice, adrenal morphology is normal, but Cyp11b2 expression and plasma aldosterone levels are elevated. Male Clcn2 R180Q/+ mice have increased aldosterone:renin ratios as well as elevated blood pressure levels. The counterpart knockout model ( Clcn2 −/− ), in contrast, requires elevated renin levels to maintain normal aldosterone levels. Adrenal slices of Clcn2 R180Q/+ mice show increased calcium oscillatory activity. Together, our work provides a knockin mouse model with a mild form of primary aldosteronism, likely due to increased chloride efflux and depolarization. We demonstrate a role of ClC-2 in normal aldosterone production beyond the observed pathophysiology.

          Abstract

          Mutations in the chloride channel ClC-2 have been associated with familial forms of hyperaldosteronism. Here, Schewe et al. generated a mouse model carrying the most common mutation found in patients and find it recapitulates key features of the disease, providing a unique tool for future studies on its pathogenesis.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

          To develop clinical practice guidelines for the management of patients with primary aldosteronism.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

            We prospectively investigated the prevalence of curable forms of primary aldosteronism (PA) in newly diagnosed hypertensive patients. The prevalence of curable forms of PA is currently unknown, although retrospective data suggest that it is not as low as commonly perceived. Consecutive hypertensive patients referred to 14 hypertension centers underwent a diagnostic protocol composed of measurement of Na+ and K+ in serum and 24-h urine, sitting plasma renin activity, and aldosterone at baseline and after 50 mg captopril. The patients with an aldosterone/renin ratio >40 at baseline, and/or >30 after captopril, and/or a probability of PA (by a logistic discriminant function) > or =50% underwent imaging tests and adrenal vein sampling (AVS) or adrenocortical scintigraphy to identify the underlying adrenal pathology. An aldosterone-producing adenoma (APA) was diagnosed in patients who in addition to excess autonomous aldosterone secretion showed: 1) lateralized aldosterone secretion at AVS or adrenocortical scintigraphy, 2) adenoma at surgery and pathology, and 3) a blood pressure decrease after adrenalectomy. Evidence of excess autonomous aldosterone secretion without such criteria led to a diagnosis of idiopathic hyperaldosteronism (IHA). A total of 1,180 patients (age 46 +/- 12 years) were enrolled; a conclusive diagnosis was attained in 1,125 (95.3%). Of these, 54 (4.8%) had an APA and 72 (6.4%) had an IHA. There were more APA (62.5%) and fewer IHA cases (37.5%) at centers where AVS was available (p = 0.002); the opposite occurred where AVS was unavailable. In newly diagnosed hypertensive patients referred to hypertension centers, the prevalence of APA is high (4.8%). The availability of AVS is essential for an accurate identification of the adrenocortical pathologies underlying PA.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

              Endocrine tumors such as aldosterone-producing adrenal adenomas (APAs), a cause of severe hypertension, feature constitutive hormone production and unrestrained cell proliferation; the mechanisms linking these events are unknown. We identify two recurrent somatic mutations in and near the selectivity filter of the potassium (K(+)) channel KCNJ5 that are present in 8 of 22 human APAs studied. Both produce increased sodium (Na(+)) conductance and cell depolarization, which in adrenal glomerulosa cells produces calcium (Ca(2+)) entry, the signal for aldosterone production and cell proliferation. Similarly, we identify an inherited KCNJ5 mutation that produces increased Na(+) conductance in a Mendelian form of severe aldosteronism and massive bilateral adrenal hyperplasia. These findings explain pathogenesis in a subset of patients with severe hypertension and implicate loss of K(+) channel selectivity in constitutive cell proliferation and hormone production.
                Bookmark

                Author and article information

                Contributors
                ute.scholl@charite.de
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                14 November 2019
                14 November 2019
                2019
                : 10
                : 5155
                Affiliations
                [1 ]ISNI 0000 0001 2218 4662, GRID grid.6363.0, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin Berlin Institute of Health, Department of Nephrology and Medical Intensive Care, ; Augustenburger Platz 1, Berlin, 13353 Germany
                [2 ]GRID grid.484013.a, Berlin Institute of Health (BIH), ; Anna-Louisa-Karsch-Str. 2, 10178 Berlin, Germany
                [3 ]ISNI 0000 0001 2218 4662, GRID grid.6363.0, Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, BIH Center for Regenerative Therapies, ; Föhrer Str. 15, Berlin, 13353 Germany
                [4 ]ISNI 0000 0001 2176 9917, GRID grid.411327.2, Department of Nephrology, School of Medicine, , Heinrich-Heine-Universität Düsseldorf, ; Universitätsstraße 1, 40225 Düsseldorf, Germany
                [5 ]ISNI 0000 0001 1014 0849, GRID grid.419491.0, Max Delbruck Center for Molecular Medicine in the Helmholtz Association, ; Berlin, Germany
                [6 ]ISNI 0000 0001 1014 0849, GRID grid.419491.0, Experimental and Clinical Research Center, a cooperation of Charité-Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, ; Lindenberger Weg 80, Berlin, 13125 Germany
                [7 ]ISNI 0000 0001 2218 4662, GRID grid.6363.0, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, ; Berlin, Germany
                [8 ]ISNI 0000 0000 9116 8976, GRID grid.412469.c, Department of Physiology, , Universitätsmedizin Greifswald, ; Friedrich-Ludwig-Jahn-Str. 15a, 17475 Greifswald, Germany
                [9 ]ISNI 0000 0001 2297 375X, GRID grid.8385.6, Institute of Complex Systems, Zelluläre Biophysik (ICS-4), Forschungszentrum Jülich, ; 52425 Jülich, Germany
                Author information
                http://orcid.org/0000-0003-3334-3950
                http://orcid.org/0000-0003-3650-5644
                http://orcid.org/0000-0002-2339-0545
                http://orcid.org/0000-0002-0309-8045
                Article
                13033
                10.1038/s41467-019-13033-4
                6856192
                31727896
                0fca9e46-ff75-4dc8-87c8-3da98f310fb4
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 7 February 2019
                : 17 October 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100001659, Deutsche Forschungsgemeinschaft (German Research Foundation);
                Award ID: SFB 1365
                Award ID: SCHO 1386/2-1, SFB 1365
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100003390, Fritz Thyssen Stiftung (Fritz Thyssen Foundation);
                Award ID: 10.16.1.027MN
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                adrenal gland diseases,experimental models of disease
                Uncategorized
                adrenal gland diseases, experimental models of disease

                Comments

                Comment on this article